1. Principle This kit is based on the specific reaction of antibody-antigen and immunochromatography. β-lactam and tetracyclines antibiotics in the sample compete for the antibody with the antigen coated on the membrane of the test strip. Then after a color reaction, the result can be observed. 2. Applications This kit is used for rapid qualitative analysis of β-lactam and tetracyclines in milk sample.
The COVID-19 IgG/IgM (Whole Blood/Serum/Plasma) Rapid Test Device utilizes lateral flow technology that is used for the qualitative, differential detection of both anti-SARS-CoV-2 IgM and IgG antibodies. In general, antibodies can be detected 1-3 weeks after infection. This test is intended to screen patients for COVID-19. Combining RNA and Antibody tests can significantly raise the sensitivity for detecting COVID-19 in infected individuals. This test has been authorized by the FDA under a EUA for professional use CLIA and CLIA WAIVED for Point Of Care. This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens. This product is intended for professional use and not for home use. FACT SHEET FOR HEALTHCARE PROVIDERS This test has been authorized by the FDA under a EUA for use by authorized CLIA laboratories. This device is CLIA waived for point of care use for fingerstick whole blood specimens only. The user should be trained in the procedure. Wear appropriate protective attire for your safety when handling patient samples. This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens. There should be a blue line in the control region (next to ) before testing, discard the device if there is no blue line.
PCR Swabs Red Medium Clear Medium VTM UTM
Rapid SAR-CoV-2 (Covid-19) Test Kits: FDA & CE Approved (Results in 15 min). SAR-CoV-2 IgG/IgM Rapid Test Cassette is a qualitative membrane based immunoassay for the detection of IgG and IgM antibodies to SAR-CoV-2 in human whole blood, serum or plasma specimen. Made in China: FDA and CE Approved, China NMPA approval (export allowed) One of the earliest CE (Feb 2020) and FDA (Mar 2020) approved kit. Clinically studied and reliable. Packaging: 20 sets/box or 40 sets/box. Payment term: MOQ 2000 sets, FOB China $ 9.5/set. < 10000 sets 100% advance payment > 10000 sets L/C ex-work on site
- Abbott Nasal POC - Abbott Nasopharyngeal POC - Genrui POC - VivaDiag Saliva POC - FaStep Saliva POC
After the virus infection, the antibody IgM appears and rises in the early stage, while antibody IgG appears and rises in the late stage. â?¢ By combining IgG and IgM, we can know if the body is infected and at which stage . the Kit inckude: Novel Coronavirus (2019-nCoV) IgG/IgM Test Kit (Colloidal Gold) â?¢ Transport or store at room temperature from 2 to 30°C â?¢ If individual pouch unopened, the kit can be stored for 12 months. â?¢ Once the individual pouch is opened, this test card should be used within 1 hour.
Specification Product Name VivaDiag SARS-CoV-2 IgM/IgG Rapid Test (COVID-19 IgM/IgG Rapid Test) Test Principle Colloidal gold Sample Type Whole blood (fingertip/venous ), serum or plasma Sample Volume 10 �¼L Test Time 15 min Operation Temperature 15-30 Storage Temperature 2-30 Shelf Life (Unopened) 24 months
Covi-G (powered by Cipla) Rapid Test kit combines quality, efficacy and convenience - offering precise results in 10-15 mins Features & Benefits Covid IgM-IgG Serologic Rapid Test for COVID-19 is used to qualitatively detect IgG and IgM antibodies against SARS-CoV-2 in whole blood in vitro Precise and effective - Tests for both IgM and IgG antibodies - Sensitivity and specificity comparable to highest available offerings Sensitivity: IgG 92%, IgM 82%; Specificity IgG 97%, IgM 94% - ->92% total accuracy: IgG 96,5% - IgM: 92,8% - High reproducibility (consistent results across the same patient) - High quality, reliable & convenient - Single-prick blood test - 10-15 minutes per test - Intuitive visual interpretation - No specialized training or equipment needed - Portable hence highly scalable - Storage at room temperature (2-30 C) - Conformance to CE (Europe) and ISO manufacturing The Covi-G platform for Rapid Antibody tests has a set of unique and unparalleled offerings SUSTAINABLE QUALITY Validated Declaration of CE conformity - Launched in Feb 2020, among the earliest technologies/ kits to declare CE-compliance, and continuing strong compared to competitors - Under process for receiving USDA E authorization Among only 3 integrated vendors of Rapid tests Developed and manufactured in Europe (Belgium) - One of the very lew players manufacturing in Europe, with zero complaints also certified locations ACCEPTABILITY ACROSS MARKETS Demonstrated capabilities in local countries validation - Independent local studies conducted in Belgium and France, validating the sensitivity and specificity of the product Participated in published research - Covl-G kit compared lavorably with 7 lgFL IgM rapid antibody tests and IgG ELISA in a comparative study published by Elsevier Science Direct, verifying sensitivity of the kit PROVEN COMMERCIAL EXPERIENCE Sold in 25+ countries already - Including Europe, US, Canada, Africa and multiple developed and emerging markets - Under participation in govt tenders Robust manufacturing capability and capacity - ISO-certified manufacturing site - Ability to cater to high manufacturing volumes from Belgium, to ensure adequale QA and commercial viability AFFORDABLE AND SCALABLE Viable to scale up at Institutions and Retail level - Economical cost per-unit established over many months of process improvement and local manufacturing - Can cater to insured as well as out-of pocket populations Continuous improvement through R&D - Multiple rounds of performance testing complete, further testing in 5 reputed hospitals underway in Belgium, France, USA and Canada - Other platforms including Rapid antigen testing also being developed The price is per unit, the minimum is 25000 units
ANDiS SARS-CoV-2 RT-qPCR Detection Kit ANDiS SARS-CoV-2 and Influenza A/B RT-qPCR Detection Kit ANDiS 350 Automated Nucleic Acid Extraction System
Certification - Test Report/CE Daily manufacturer output - TBD Price - $25 Volume dependent
Reagent Test Strip iChem VELOCITY Urinalysis Multiple Analytes For iChem VELOCITY Systems 100 Strips UOM: 100/BX Product Number: 800-7212 Manufacturer: Beckman Coulter
We have iHeath finally OTG LA California .... ICPO/POF/CI/Inspect and pay at iHealth warehouse... 8.50+ depending on quantity.....
[CONTENTS] (25) Test Kits (25) Individual Test Kits (25) Serum Pipets (1) Instruction For Use SENSITIVITY 100% | SPECIFICITY 97.3%
Nitrile gloves, n95 masks, covid-19 rapid diagnostics antibody tests, rt-pcr covid-19 testing kits, nasal swabs, water treatment ro units.
Boson rapid antigen tests kits boxes of 20
Reagent Cobas Liat Nucleic Acid Test Influenza A / B, Respiratory Syncytial Virus (RSV) For Cobas Liat Automated PCR Analyzer 20 Tests 20 Tubes UOM: 20/CS Product Number: 08160104190 Manufacturer: Roche
Authorized reseller of Access Bio & Celltrion Rapid COVID-19 Antigen Tests (2 Pack). Please contact for more details whether one time buy or contract orders.
Official Sales Partner for Master Distributor of iHealth Rapid Test NOT A BROKER OR RE-SELLER AVAILABLE FOR IMMEDIATE DELIVERY IN THE USA FDA AUTHORIZED 15 MINS SELF-TEST Product Description The iHealth COVID-19 Antigen Rapid Test is a lateral flow assay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older with symptoms of COVID-19 within the first 7 days of symptom onset. This test is also authorized for non-prescription home use with adult-collected nasal swab samples from individuals aged 2 years or older with symptoms of COVID-19 within the first 7 days of symptom onset. This test is also authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older, or adult collected anterior nasal swab samples from individuals aged 2 years or older, with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. Pricing: $9 PER KIT OF 2 TESTS MOQ: 1 pallet: 84 cartons / 7560 boxes / 15,120 tests Maximum Quantity: Please inquire Shipping Information: 90 Packs per Carton, 2 Tests per Pack 1 pallet: 84 cartons / 7560 boxes 1100 lbs Per pallet Single Package Dimensions (LxWxH) 6.18 x 3.19 x 0.71 Inches Single Package Weight (lb) 0.13 Carton Dimensions (LxWxH) 13.1 x 11.8 x 10.8 Inches Carton Weight (lb) 12.8 *Prices subject to change without notice
CareStarfTM COVID-19 ANTIGEN RAPID TESTS Why CareStartTM COVID-19 Live infection 10 minutes Diagnostic Tests dose not require a machine reader! Abbott, Quidel, and BD require readers, that are in short supply. â?¢ EASY TO USE CareStart â?¢ AVAILABILE Rapid Tests on the shelf available products (in inventory) with We offer CareStartTM reliable production and delivery schedules. Abbott, Quidel and BD testing cassettes are in short supply with unreliable availability. â?¢ FDA EUA is currently the only Point-Of-Care rapid antigen test registered authorized under the FDA EUA. CareStart TM CareStarfTM COVID-19 ANTIGEN RAPID TESTS Features Identify individual's current infection status to COVID-19 Fast and easy to use in Point-of-Care setting Qualitatively detect the SARS-CoV-2 nucleocapsid protein Use nasopharyngeal (NP) swab specimens Reliable results only in 1O minutes No special equipment or training required All-in-one package including collection swabs High sensitivity (88.4�°/o) and specificity (100�°/o) Kit Components 20 test devices 20 extraction vials and caps 20 NP swabs 1 positive and 1 negative controls Package insert Quick reference Instructions (QRI)
We can provide Covid-19 Rapid Antigen Test. Test with reliable results within minutes. Made in the USA. Lateral flow assay, No equipment required, Results within 10 minutes, minimally invasive specimen collection, nasal swab, POC (in patient care setting). Detects SARS-CoV2 nucleocapsid protein antigen with ultra high performance. Identifies acute infection with 88.4% sensitivity and 100% specificity. Complies with FDA. Principals or Buyer's Mandates only. No broker chains. FOB or CIF. Minimum order 500000 test please.
